A real-world study analysing safety and efficacy of rituximab biosimilar CT-P10 (Truxima R) with CHOP as first-line treatment for patients with diffuse large B-cell lymphoma
Latest Information Update: 17 May 2021
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- 17 May 2021 New trial record